National Survey on GERD Patients (Adults and Children) (RGO à trav)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00833573
First received: January 30, 2009
Last updated: November 13, 2009
Last verified: November 2009

January 30, 2009
November 13, 2009
January 2009
Not Provided
To describe GERD digestive expression according to ages: - children (from 0-23 months) and (24 months and more)- adults (from 18-29 years old), (from 30-39 years old), (from 40-49 years old), (from 50-59 years old), (more than 60 years old) [ Time Frame: once ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00833573 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
National Survey on GERD Patients (Adults and Children)
National Survey on GERD Patients (Adults and Children)

To describe GERD digestive expression according to ages: - children (from 0 to 23 months) and (24 months and more)- adults (from 18 to 29 years old), (from 30 to 39 years old), (from 40 to 49 years old), (from 50 to 59 years old), (more than 60 years old)

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample

For GP : the first 3 consecutive adult patients and the first children seen during the GP's visit with a diagnosis of GERD.For Paediatrics : the first 2 consecutive children seen during the Paediatric's visit with a diagnosis of GERD.

GERD (Gastroesophageal Reflux Disease)
Not Provided
  • 1
    For GP : the first 3 consecutive adult patients and the first children seen during the GP's visit with a diagnosis of GERD.
  • 2
    For Paediatrics : the first 2 consecutive children seen during the Paediatric's visit with a diagnosis of GERD.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4400
October 2009
Not Provided

Inclusion Criteria:

  • Adults : - Male or female > or = 18 years old - With at least one GERD typical clinical sign (pyrosis and / or acid regurgitations).- Not receiving any GERD treatment within the 3 previous months.
  • Children :- Male or female < 18 years old - With GERD digestive clinical signs during the consultation (receiving treatment or not)- Whose parents or legal guardian gave oral approval to the child participation in the survey.

Exclusion Criteria:

-

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00833573
NIS-GFR-DUM-2008/2
No
Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
AstraZeneca
Not Provided
Study Director: Alain Castaigne AstraZeneca
AstraZeneca
November 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP